Not Applicable
Not Applicable
1. Field of Invention
This invention relates to devices to treat aneurysms.
2. Background and Review of Related Art
An aneurysm is an abnormal bulging or ballooning of a blood vessel. Rupture of brain aneurysms can cause stroke, death, or disability. Around one-third of people who have a brain aneurysm that ruptures will die within 30 days of the rupture. Of the survivors, around half of them suffer some permanent loss of brain function. Many aneurysms are not identified until they rupture. However, identification of intact aneurysms is increasing due to increased outpatient imaging. Ruptured aneurysms must be treated to stop the bleeding or to prevent re-bleeding. Intact aneurysms may or may not be treated to prevent rupture, depending on their characteristics. Wide neck aneurysms are less prone to rupture, but are harder to treat. In the U.S., it has been estimated that over 10 million people have brain aneurysms and 30,000 people each year have a brain aneurysm that ruptures.
Several approaches can be used to treat brain aneurysms. These different approaches can be divided into three categories: (1) approaches involving treatment outside the vessel; (2) approaches involving treatment inside the aneurysm; and (3) approaches involving treatment in the parent vessel. Some of these approaches can be used together. Each of these approaches has some disadvantages, as discussed below.
1. Treatment Outside the Vessel
Clipping: Clipping is the application of a small clip to the aneurysm neck from outside the vessel to seal off the aneurysm. For most brain aneurysms, this involves invasive surgery including removing a section of the skull. Clipping began in the 1930's and is well-established. Clipping is more common in the U.S. than in Europe. Around half of all aneurysms are treated by clipping. There are many aneurysm clips in the prior art. However, due to its invasive nature, clipping is decreasing. Potential disadvantages of clipping can include: significant health risks associated with major surgery of this type; and long recovery times, even when the surgery itself goes well.
2. Treatment Inside the Aneurysm
Metal Coils: Metal coiling is the endovascular insertion of metal coils into the aneurysm to reduce blood flow and promote embolization in the aneurysm. Historically, metal coils have been platinum. Coils are more common in Europe than in the U.S. There are many examples of metal coils. Potential disadvantages of metal coils can include: low percentage of aneurysm volume filled (low occlusion is associated with a higher risk of rupture); compaction of coils over time; risk of recanalization; potential prolapse of coils into the parent vessel; difficulty later clipping aneurysms filled with metal coils, if needed; pressure from the coils on surrounding brain tissue; inability of coils to treat all aneurysms; and expense of metal coils (especially platinum coils).
Combination Metal/Textile/Foam/Gel Coils: Coils with a combination of metal and other materials can be used to try to achieve greater occlusion volume than metal coils alone. These other materials include textile, foam, and gel elements. Textile strands can be woven into the coils to add bulk. Coils can be covered with soft foam. Gel elements can be strung together into elongated structures. Examples of related art that appear to use this approach includes the following: U.S. Pat. No. 5,382,259 (Phelps et al.), U.S. Pat. No. 5,522,822 (Phelps et al.), U.S. Pat. No. 5,690,666 (Berenstein et al.), U.S. Pat. No. 5,718,711 (Berenstein et al.), U.S. Pat. No. 5,749,894 (Engelson), U.S. Pat. No. 5,976,162 (Doan et al.), U.S. Pat. No. 6,024,754 (Engelson), U.S. Pat. No. 6,299,619 (Greene, Jr. et al.), U.S. Pat. No. 6,602,261 (Greene, Jr. et al.), U.S. Pat. No. 6,723,108 (Jones et al.), U.S. Pat. No. 6,979,344 (Jones et al.), U.S. Pat. No. 7,070,609 (West), and U.S. Pat. No. 7,491,214 (Greene, Jr. et al.), and U.S. Patent Applications 20040158282 (Jones, Donald et al.), 20050267510 (Razack, Nasser), and 20060058834 (Do, Hiep et al.). Potential disadvantages of combination coils can include: remaining gaps between loops; compaction of coils over time; risk of recanalization; potential prolapse of coils into the parent vessel; difficulty clipping aneurysms filled with coils with metal components later if needed; pressure from the coils on surrounding brain tissue; inability of coils to treat all aneurysms; and expense of metal coils.
Inflatable Balloons: Approximately two decades ago, there were numerous efforts to treat aneurysms by permanently filling them with inflatable balloons. These efforts were largely abandoned due to the risks of balloon deflation, prolapse into the parent vessel, aneurysm rupture, and recanalization. There are, however, examples of relatively recent art that appear to use inflatable balloons to treat aneurysms: U.S. Pat. No. 6,569,190 (Whalen et al.) and U.S. Pat. No. 7,083,643 (Whalen et al.), and U.S. Patent Applications 20030135264 (Whalen et al.), 20030187473 (Berenstein, Alejandro et al.), 20060292206 (Kim, Steven et al.), 20070050008 (Kim, Steven et al.), and 20070055355 (Kim, Steven et al.). Potential disadvantages of using inflatable balloons to permanently fill aneurysms can include: balloon deflation; prolapse of the balloon into the parent vessel; aneurysm rupture due to balloon pressure; and recanalization.
Manually-Activated Mesh Occluders: Another approach to treating aneurysms involves inserting into the aneurysm a mesh structure, generally metal, that can be expanded or contracted by human-controlled mechanical motion so as to block the aneurysm neck and/or to fill the main volume of the aneurysm. For example, a wire structure can be inserted through the aneurysm neck in a narrow configuration and then transformed into an “hour-glass” shape that collapses to block the aneurysm neck when activated by a human controller. Examples of related art that appear to use this approach include the following: U.S. Pat. No. 5,928,260 (Chin et al.), U.S. Pat. No. 6,344,048 (Chin et al.), U.S. Pat. No. 6,375,668 (Gifford et al.), U.S. Pat. No. 6,454,780 (Wallace), U.S. Pat. No. 6,746,468 (Sepetka et al.), U.S. Pat. No. 6,780,196 (Chin et al.), and U.S. Pat. No. 7,229,461 (Chin et al.), and U.S. Patent Applications 20020042628 (Chin, Yem et al.), 20020169473 (Sepetka, Ivan et al.), 20030083676 (Wallace, Michael), 20030181927 (Wallace, Michael), 20040181253 (Sepetka, Ivan et al.), 20050021077 (Chin et al.), 20060155323 (Porter, Stephen et al.), 20070088387 (Eskridge, Joseph et al.), 20070106311 (Wallace, Michael et al.), and 20080147100 (Wallace, Michael). Potential disadvantages of such manually-activated metal occluders include: difficulty engaging the necks of wide-neck aneurysms; difficulty filling irregularly-shaped aneurysms with standard-shaped mesh structures; risk of rupture when pinching the aneurysm neck or pushing on the aneurysm walls; and protrusion of the proximal portion of “hour-glass” designs into the parent vessel.
Self-Expanding Standard-Shape Occluders: Another approach to treating aneurysms uses standard-shaped structures that self-expand when released into the aneurysm. For example, the structure may be a mesh of “shape memory” metal that automatically expands to a standard shape when released from the confines of the catheter walls. As another example, the structure may be a gel that expands to a standard shape when exposed to moisture. Examples of related art that appear to use this approach include the following: U.S. Pat. No. 5,766,219 (Horton), U.S. Pat. No. 5,916,235 (Guglielmi), 5,941,249 (Maynard), U.S. Pat. No. 6,409,749 (Maynard), U.S. Pat. No. 6,506,204 (Mazzocchi), U.S. Pat. No. 6,605,111 (Bose et al.), U.S. Pat. No. 6,613,074 (Mitelberg et al.), U.S. Pat. No. 6,802,851 (Jones et al.), U.S. Pat. No. 6,811,560 (Jones et al.), U.S. Pat. No. 6,855,153 (Saadat), U.S. Pat. No. 7,083,632 (Avellanet et al.), U.S. Pat. No. 7,306,622 (Jones et al.), and U.S. Pat. No. 7,491,214 (Greene, Jr. et al.), and U.S. Patent Applications 20030093097 (Avellanet, Ernesto et al.), 20030195553 (Wallace, Michael et al.), 20050033349 (Jones, Donald et al.), 20060052816 (Bates, Brian et al.), and 20060235464 (Avellanet, Ernesto et al.) and WIPO Patents WO/2006/084077 (Porter, Stephen et al.) and WO/1996/018343 (McGurk et. al.). Potential disadvantages of such self-expanding standard-shape structures can include: risk of prolapse into the parent vessel, especially for wide-neck aneurysms; difficulty occluding irregularly-shaped aneurysms with standard shape structures and associated risk of recanalization; and difficulty generating the proper amount of force (not too much or too little) when engaging the aneurysm walls with a standard-shaped self-expanding structure.
Self-Expanding Custom-Modeled Occluders: A variation on self-expanding standard-shape occluders (discussed above) are self-expanding occluders that are custom modeled before insertion so as to fit the shape of a particular aneurysm. As an example sequence—the aneurysm can be imaged, the image is used to custom model the occluding structure, the occluding structure is compressed into a catheter, the occluding structure is inserted into the aneurysm, and the occluding structure then self-expands to fill the aneurysm. The occluding structure may be made from a gel that expands upon contact with moisture. Examples of related art that appear to use this approach include the following: U.S. Pat. No. 5,766,219 (Horton), U.S. Pat. No. 6,165,193 (Greene, Jr. et al.), U.S. Pat. No. 6,500,190 (Greene, Jr. et al.), U.S. Pat. No. 7,029,487 (Greene, Jr. et al.), and U.S. Pat. No. 7,201,762 (Greene, Jr. et al.), and U.S. Patent Application 20060276831 (Porter, Stephen et al.). Potential disadvantages of self-expanding custom-modeled occluders can include: the complexity and expense of imaging and modeling irregularly-shaped aneurysms; difficulty compressing larger-size structures into a catheter; difficulty inserting the occluding structure in precisely the correct position; and difficulty getting a gelatinous surface to anchor solidly to aneurysm walls.
Congealing Liquid or Gel: Another approach to treating aneurysms involves filling an aneurysm with a liquid or gel that congeals rapidly. Examples of related art that appear to use this approach include the following: U.S. Pat. No. 6,569,190 (Whalen et al.), U.S. Pat. No. 6,626,928 (Raymond et al.), U.S. Pat. No. 6,958,061 (Truckai et al.), and U.S. Pat. No. 7,083,643 (Whalen et al.), and U.S. Patent Application 20030135264 (Whalen et al.). Potential disadvantages of a congealing liquid or gel can include: leakage of the congealing substance into the parent vessel, potentially causing a stroke; difficulty filling the entire aneurysm if the substance begins to congeal before the aneurysm is full; and seepage of toxic substances into the blood stream.
Biological or Pharmaceutical Agents: Biological and/or pharmaceutical agents can enhance the performance of a variety of mechanical treatment methods for aneurysms. For example, they can speed up the natural embolization process to occlude the aneurysm. Examples of related art that appear to use this approach include the following: U.S. Patent Applications 20060206139 (Tekulve, Kurt J.), 20070168011 (LaDuca, Robert et al.), and 20080033341 (Grad, Ygael). Currently, biological and/or pharmaceutical approaches are not sufficient as stand alone treatment approaches for many cases. Accordingly, they share most of the potential disadvantages of the baseline approach to which the biological or pharmaceutical agents are added.
Embolic-Emitting Expanding Members: Another approach involves an expanding member within the aneurysm that emits embolic elements into the aneurysm. Examples of such expanding members include bags, meshes, and nets. Examples of embolic elements include coils and congealing liquids. This can be viewed as another way to block the aneurysm neck while delivering embolics into the volume of the aneurysm. For example, the distal portion of an expanding bag may leak embolic elements into the aneurysm, but the proximal portion of the expanding member does not leak embolics into the parent vessel. Examples of related art that appear to use this approach include the following: U.S. Pat. No. 6,547,804 (Porter et al.) and U.S. Patent Applications 20040098027 (Teoh, Clifford et al.), 20060079923 (Chhabra, Manik et al.), and 20080033480 (Hardert, Michael). Potential disadvantages are as follows. Since the expanding member “leaks,” it may have insufficient expansion force to adequately anchor against the aneurysm walls or to seal off the aneurysm neck. As a result of poor anchoring, the bag may prolapse into the parent vessel. Also, as a result of poor sealing of the aneurysm neck, embolics may leak into the parent vessel.
Shape Memory Structures inside Expanding Members: A variation on the shape memory approach above involves the addition of an expanding member around the shape memory structure. Examples of related art that appear to use this approach include the following: U.S. Pat. No. 5,861,003 (Latson et al.), U.S. Pat. No. 6,346,117 (Greenhalgh), U.S. Pat. No. 6,350,270 (Roue), U.S. Pat. No. 6,391,037 (Greenhalgh), and U.S. Pat. No. 6,855,153 (Saadat). The potential disadvantages of this approach are similar to those for uncovered shape memory occluders: risk of prolapse into the parent vessel, especially for wide-neck aneurysms; difficulty occluding irregularly-shaped aneurysms with standard shape structures and associated risk of recanalization; and difficulty generating the proper amount of force (not too much or too little) when engaging the aneurysm walls with a standard-shaped self-expanding structure.
Accumulating Coils inside Expanding Members: A variation on the standard coiling approach above involves the addition of an expanding member around the accumulating coils. Examples of related art that appear to use this approach include the following: U.S. Pat. No. 5,334,210 (Gianturco), U.S. Pat. No. 6,585,748 (Jeffree), and U.S. Pat. No. 7,153,323 (Teoh et al.), and U.S. Patent Applications 20060116709 (Sepetka, Ivan et al.), 20060116712 (Sepetka, Ivan et al.), and 20060116713 (Sepetka, Ivan et al.). Potential disadvantages of this approach are similar to those for coils alone, including: compaction of coils over time; risk of recanalization due to “bumpy” coil-filled expanding member; difficulty clipping aneurysms filled with metal coils later if needed; pressure from the coils on surrounding brain tissue; inability to treat all aneurysms; and expense of metal coils (especially platinum coils).
3. Treatment in the Parent Vessel
Standard (High-Porosity) Stent: A stent is a structure that is inserted into a vessel in a collapsed form and then expanded into contact with the vessel walls. Standard stents are generally highly porous, metal, and cylindrical. A high-porosity stent allows blood to flow through the stent walls if there are any branching or secondary vessels in the vessel walls. Blood flow through a stent wall into a branching or secondary vessel is desirable, but blood flow through a stent wall into an aneurysm is not. Accordingly, a high-porosity stent in the parent vessel is not a good stand-alone aneurysm treatment. A high-porosity stent in the parent vessel can, however, help to keep coils or other embolic members from escaping out of the aneurysm into the parent vessel.
Examples of related art that appear to use this approach include the following: U.S. Pat. No. 6,096,034 (Kupiecki et al., 2000), U.S. Pat. No. 6,344,041 (Kupiecki et al., 2002), U.S. Pat. No. 6,168,592 (Kupiecki et al., 2001), and U.S. Pat. No. 7,211,109 (Thompson, 2007). Potential disadvantages of this approach can include many of the problems associated with use of the embolic members alone. For example, using a high-porosity stent in the parent vessel in combination with coils in the aneurysm still leaves the following disadvantages of using coils alone: low percentage of aneurysm volume filled (and low occlusion is associated with a higher risk of rupture); compaction of coils over time; significant risk of recanalization; difficulty clipping aneurysms filled with metal coils later if needed; pressure from the coils on surrounding brain tissue; inability of coils to treat all aneurysms; and expense of metal coils (especially platinum coils).
Uniformly Low-Porosity Stent: Another approach involves inserting a uniformly low-porosity stent into the parent vessel. The low-porosity stent blocks the flow of blood through the stent walls into the aneurysm, causing beneficial embolization of the aneurysm. For example, the stent may have one or more layers that are impermeable to the flow of liquid. Unlike a standard (high-porosity) stent, this approach can be used as a stand-alone aneurysm treatment. Examples of related art that appear to use this approach include the following: U.S. Pat. No. 5,645,559 (Hachtman et al., 1997), U.S. Pat. No. 5,723,004 (Dereume et al., 1998), U.S. Pat. No. 5,948,018 (Dereume et al., 1999), U.S. Pat. No. 6,165,212 (Dereume et al., 2000), U.S. Pat. No. 6,063,111 (Hieshima et al., 2000), U.S. Pat. No. 6,270,523 (Herweck et al., 2001), U.S. Pat. No. 6,331,191 (Chobotov, 2001), U.S. Pat. No. 6,342,068 (Thompson, 2002), U.S. Pat. No. 6,428,558 (Jones et al., 2002), U.S. Pat. No. 6,656,214 (Fogarty et al., 2003), U.S. Pat. No. 6,673,103 (Golds et al., 2004), U.S. Pat. No. 6,790,225 (Shannon et al., 2004), and U.S. Pat. No. 6,786,920 (Shannon et al., 2004), and U.S. Patent Application 20080319521 (Norris et al., 2008). Potential disadvantages of this approach can include: undesirably blocking blood flow to branching or secondary vessels that are close to the aneurysm and are covered by the stent wall; difficulty achieving a snug fit across the neck of the aneurysm if the parent vessel is curved, twisted, or forked; and poor attachment of the stent with the parent vessel wall due to the impermeable nature of the stent wall.
Uniformly Intermediate-Porosity Metal Stent: This approach pursues creation of a stent with a uniform intermediate porosity that provides a compromise between the benefits of a high-porosity stent in the parent vessel (good blood flow to nearby branching or secondary vessels) and the benefits of a low-porosity stents in the parent vessel (blocking blood flow to the aneurysm). Examples of related art that appear to use this approach include the following: U.S. Pat. No. 6,770,087 (Layne et al., 2004), U.S. Pat. No. 7,052,513 (Thompson, 2006), and U.S. Pat. No. 7,306,624 (Yodfat et al., 2007), and U.S. Patent Applications 20070207186 (Scanlon et al.,2007), 20070219619 (Dieck et al., 2007), 20070276470 (Tenne, 2007), 20070276469 (Tenne, 2007), and 20080039933 (Yodfat et al., 2008). The main potential disadvantage of this approach is that it may perform neither function very well. It may unreasonably block flow to a branching or secondary vessels (causing a stroke) and may inadequately block blood flow to the aneurysm (leaving it vulnerable to rupture).
Pre-Formed Differential Porosity Stent: This approach involves creating a stent with different levels of porosity for different wall areas, before the stent is inserted into the parent vessel. The goal is two-fold: (1) to place wall areas with high porosity over openings to branching or secondary vessels; and (2) to place wall areas with low porosity over the neck of the aneurysm. Examples of related art that appear to use this approach include the following: U.S. Pat. No. 5,769,884 (Solovay,1998), U.S. Pat. No. 5,951,599 (McCrory, 1999), U.S. Pat. No. 6,309,367 (Boock, 2001), U.S. Pat. No. 6,309,413 (Dereume et al., 2001), U.S. Pat. No. 6,165,212 (Dereume et al., 2000), U.S. Pat. No. 5,948,018 (Dereume et al.,1999), U.S. Pat. No. 5,723,004 (Dereume et al., 1998), and U.S. Pat. No. 7,186,263 (Golds et al., 2007), and U.S. Patent Applications 20070219610 (Israel, 2007), 20070239261 (Bose, et al., 2007), and 20080004653 (Sherman et al., 2008). Potential disadvantages of this approach include: difficultly matching a specific anatomic configuration (curvature, branching, neck size, etc) with a preformed stent; difficulty of precise placement of the stent to properly align the porous and non-porous areas with branching vessels and the aneurysm, respectively; and difficulty creating low porosity areas in a compressed state that maintain this low porosity in an expanded state.
Post-Implantation Filling Between Stent Wall and Vessel Wall: This approach fills the gap between the wall of the stent and the wall of the parent vessel with an embolizing substance such as a liquid or gel that solidifies after insertion. Examples of related art that appear to use this approach include the following: U.S. Pat. No. 5,769,882 (Fogarty et al., 1998) and U.S. Patent Application 20070150041 (Evans et al., 2007). Potential disadvantages of this approach include: difficulty injecting the embolizing substance through the stent wall without having it leak back into the parent vessel; leakage of embolizing liquid or gel between the stent and the parent vessel into the blood stream, where it blocks a downstream vessel and causes a stroke; challenges containing the embolic material within curving vessels or vessels with irregular walls; and difficulty using this method to fill narrow-neck aneurysms.
Post-Implantation Surface Modification: This approach creates different degrees of porosity in different wall areas after the stent is implanted. The goal is to decrease the porosity of the stent wall in the area of the aneurysm neck, but to leave the rest of the stent wall relatively porous to allow blood flow to branching or secondary members. Also, high porosity in other areas of the stent wall aids in the attachment and integration of the stent to the parent vessel. Unlike the preceding approach, this approach does not fill the gap between the stent wall and the parent vessel wall with some type of solidifying liquid, but rather modifies the wall of the stent itself This reduces the risk of embolic liquid or members leaking out between the stent and the parent vessel wall into the blood stream.
This approach remains relatively uncommon The few examples in the related art appear to expose one area of the stent wall to surface-modifying chemicals or energy emissions in order to decrease porosity of the stent wall in that area alone. Examples of related art that appear to use this approach include the following: U.S. Pat. No. 5,951,599 (McCrory, 1999) and U.S. Pat. No.7,156,871 (Jones et al., 2007). Potential disadvantages of this approach include: negative effects of surface-modifying chemicals seeping into the blood stream; negative effects of energy emissions on surrounding vessel or brain tissue; and difficulty adding enough matter to the stent wall covering the aneurysm neck by chemical or energy modification means, after stent implantation, to adequately reduce blood flow through the aneurysm neck.
To conclude this section, although there has been significant progress in developing options for treating brain aneurysms, there are still high rates of death and disability and still disadvantages to the treatment options available.
This invention can be embodied in a stent system that is inserted into the parent vessel of an aneurysm in order to reduce blood flow to the aneurysm and promote embolization of the aneurysm. The stent wall includes an inner structure, such as an expandable metal mesh, that can be expanded from a compressed state to a resilient expanded state and an outer flexible layer, such as a flexible fabric net, that covers all or part of the inner structure. Embolic members are placed and retained in the gap between the inner structure and the outer layer in the area of the aneurysm neck in order to reduce blood flow to the aneurysm.
This invention can also be embodied in a stent to reduce blood flow to an aneurysm comprising: (a) an inner member, wherein this inner member is expanded from a first configuration to a second configuration within the parent vessel of an aneurysm, wherein the circumference of the second configuration is larger than the circumference of the first configuration; and (b) an outer member, wherein this outer member is less porous than the inner member, wherein this outer member covers or surrounds a first percentage of the surface area of the inner member when the inner structure is in the first configuration, wherein this outer member covers or surrounds a second percentage of the surface area of the inner member when the inner structure is in the second configuration, and wherein the second percentage less than the first percentage.
In this embodiment, the wall of the stent consists of two layers. The inner layer of the stent wall is an expandable and resilient metal mesh structure 104 with a hexagonal pattern. Many other types of expandable mesh structures may also be used. In various examples, this inner mesh structure may be made from stainless steel, a nickel-titanium alloy, cobalt chromium or a cobalt-chromium alloy, titanium or a titanium alloy, tantalum or a tantalum allow, or polymeric-based resin or another polymer. In this embodiment, the outer layer of the stent is a flexible fabric net 105. In various examples, the outer flexible layer may be made from latex, nylon, polyester, teflon, silicone, HDPE, polycarbonate urethane, polyether-polyamide copolymer, polyethylene terephthalate, polyolefin, polypropylene, polytetrafluorethylene, polytetrafluoroethene, polyurethane, or polyvinyl chloride.
In this embodiment, there is a gap between the inner mesh structure and the outer flexible layer and these layers are not connected to each other. In other examples of this invention, there may be no gap between these layers until embolic members are inserted between them in the area of the aneurysm neck. In other examples, the two layers may be connected at multiple points or seams in order to form separate pouches between the layers for more precise localized containment of the embolic members between the layers. In other examples, the wall may be comprised of more than two layers.
In this embodiment, the embolic members are compressible micro-sponges that expand upon ejection from the catheter. In various examples, these micro-sponges may be made from cellulose, collagen, acetate, alginic acid, carboxy methyl cellulose, chitin, collagen glycosaminoglycan, divinylbenzene, ethylene glycol, ethylene glycol dimethylmathacrylate, ethylene vinyl acetate, hyaluronic acid, hydrocarbon polymer, hydroxyethylmethacrylate, methlymethacrylate, polyacrylic acid, polyamides, polyesters, polyolefins, polysaccharides, polyurethane, polyvinyl alcohol, silicone, urethane, and vinyl stearate. In other examples, the embolic members may be gels, beads, or coils.
In this embodiment, the embolic members (such as 302) are retained with the gap between the inner mesh structure 104 and outer flexible layer 105 because they expand upon ejection from the catheter 301 and can not exit the same opening in the inner mesh structure by which they entered this gap. In another example, the embolic members need not expand, but the opening by which they enter the gap may be closed when the catheter is removed to trap them within the gap.
Specifically,
In
In the examples shown in
The following are particularly-relevant quotes from the specification thus far (including page and line numbers from the original Nov. 18, 2009 specification): “a stent system that is inserted into the parent vessel of an aneurysm in order to reduce blood flow to the aneurysm and promote embolization of the aneurysm” (Nov. 18, 2009 specification, page 10, lines 23-25); “stent wall includes an inner structure . . . that can be expanded from a compressed state to a resilient expanded state and an outer flexible layer . . . that covers . . . part of the inner structure” (Nov. 18, 2009 specification, page 10, lines 25-27); “one area of the outer flexible net . . . the area may span a higher or lower percentage of the surface area of the stent” (Nov. 18, 2009 specification, page 17, line 28-page 18, line 1); “features radioopaque lateral and longitudinal lines that help the operator to align the saddle-shaped area with the aneurysm neck during placement and expansion ” (Nov. 18, 2009 specification, page 17, lines 17-19); “layers may be connected at multiple points or seams” (Nov. 18, 2009 specification, page 13, lines 30-31); and “In this embodiment . . . these layers are not connected to each other” (Nov. 18, 2009 specification, page 13, lines 27-28).
In an example, an invention can be embodied in a device that is inserted into the parent vessel of an aneurysm in order to reduce blood flow to the aneurysm, comprising: an inner structure that can be expanded from a compressed state to a resilient expanded state within the parent vessel of the aneurysm; and an outer flexible layer that covers part of the inner structure, wherein this outer flexible layer spans a first percentage of the surface area of the inner structure before expansion of the inner structure, wherein this outer flexible layer spans a second percentage of the surface area of the inner structure after expansion of the inner structure, and wherein the first percentage is higher than the second percentage. In an example, the outer flexible layer can be less porous than the inner structure. In an example, this device can further comprise radioopaque markings that help the operator to align the outer flexible layer with the aneurysm neck.
In an example, this invention can be embodied in a device that is inserted into the parent vessel of an aneurysm in order to reduce blood flow to the aneurysm, comprising: an inner structure that can be expanded from a compressed state to a resilient expanded state within the parent vessel of the aneurysm; and an outer flexible layer that covers part of the inner structure, wherein the inner structure and outer flexible layer are connected to each other at multiple points or seams, and wherein one or more of these multiple points or seams are disconnected during expansion of the inner structure. In an example, the outer flexible layer can be less porous than the inner structure. In an example, this device can further comprise radioopaque markings that help the operator to align the outer flexible layer with the aneurysm neck.
In this example, inner structure 1602 is an expandable resilient tubular mesh. In this example, outer flexible layer 1604 is a saddle-shaped net, patch, covering, and/or liner with a lower porosity than inner structure 1602. In an example, outer flexible layer 1604 can have smaller surface pores or openings (as shown in
In an example, arcuate ribs or tracks (such as 1607) can encircle the entire circumference of inner structure 1602. In an example, arcuate ribs or tracks (such as 1607) can partially encircle a portion of the circumference of inner structure 1602. In an example, arcuate ribs or tracks can fully or partially encircle the circumference of inner structure 1602 in a plane which is substantially perpendicular to the longitudinal axis of inner structure 1602. In an example, arcuate ribs or tracks (such as 1607) can expand or telescope longer when inner structure 1602 expands.
In an example, inflatable member 1603 can be a balloon. In an example, inflatable member 1603 can be inflated by filling it with a liquid, such as saline or contrast media. In an example, inflatable member 1603 can be inflated by filling it with a gas, such as carbon dioxide. In an example, this device can further comprise imaging-detectable markings (as shown in
As shown in
In the example shown in
In an example, inner structure 1602 and outer flexible layer 1604 can be connected at multiple points or seams and one or more of these points or seams can move along the circumference of the inner structure during expansion of the inner structure. In an example, inner structure 1602 and outer flexible layer 1604 can be connected at multiple points or seams and one or more of these points or seams can move on a track along the circumference of the inner structure during expansion of the inner structure.
In the example shown in
However, in this example, arcuate ribs (such as 1901) are outside outer flexible layer 1604. In this example, arcuate ribs (such as 1901) loosely hold outer flexible layer 1604 against inner structure 1602, but still allow outer flexible layer 1604 to slide around the circumference of inner structure 1602 when inner structure 1602 expands. In an example, these arcuate ribs can encircle the entire circumference of inner structure 1602. In an example, these arcuate ribs can partially encircle a portion of the circumference of inner structure 1602. In an example, these arcuate ribs can expand or telescope longer when inner structure 1602 expands. In an example, outer flexible layer 1604 is between inner structure 1602 and a plurality of expandable arcuate ribs, wherein these ribs span all or part of the circumference of inner structure, and wherein the outer flexible layer can slide between the inner structure and the expandable arcuate ribs during expansion of the inner structure. In an alternative example, the use of a flexible third layer (such as a tubular net or mesh) can serve the same function as arcuate ribs, instead of using arcuate ribs. In an example, the wall of the device may be comprised of more than two layers.
In this example, a subset (including 2202) of multiple points or seams (including 2201 and 2202) become disconnected when inner structure 1602 expands. This is another way to allow inner structure 1602 to expand without making outer flexible layer 1604 also expand. The subset of points or seams (including 2201) which remain connected when inner structure 1602 expands help to keep outer flexible layer 1604 positioned over the aneurysm neck. This is another way to create a low-porosity region over the aneurysm neck to block blood flow to the aneurysm without blocking blood flow to nearby branching vessels. In an example, the subset of multiple points or seams (including 2202) can become disconnected due to the shearing force of expansion. In an example, the subset of multiple points or seams (including 2202) can become disconnected via melting due to the application of an electrical charge. In an example, inner structure 1602 and outer flexible layer 1604 can be connected at multiple points or seams, wherein these one or more of these points or seams are disconnected during expansion of the inner structure.
In an example, this invention can be embodied in a stent to reduce blood flow to an aneurysm comprising: (a) an inner member, wherein this inner member is expanded from a first configuration to a second configuration within the parent vessel of an aneurysm, wherein the circumference of the second configuration is larger than the circumference of the first configuration; and (b) an outer member, wherein this outer member is less porous than the inner member, wherein this outer member covers or surrounds a first percentage of the surface area of the inner member when the inner structure is in the first configuration, wherein this outer member covers or surrounds a second percentage of the surface area of the inner member when the inner structure is in the second configuration, and wherein the second percentage is lower than the first percentage. In an example, the second percentage can be at least 10% less than the first percentage.
This application is a continuation-in-part of U.S. patent application Ser. No. 12/592,116—entitled “Stent with a Net Layer to Embolize an Aneurysm” filed on Nov. 18, 2009 by Robert Connor and Muhammad Tariq Janjua—the entirety of which is incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
4364392 | Strother et al. | Dec 1982 | A |
4994069 | Ritchart et al. | Feb 1991 | A |
5226889 | Sheiban | Jul 1993 | A |
5304132 | Jang | Apr 1994 | A |
5334210 | Gianturco | Aug 1994 | A |
5350397 | Palermo et al. | Sep 1994 | A |
5370691 | Samson | Dec 1994 | A |
5382259 | Phelps et al. | Jan 1995 | A |
5405379 | Lane | Apr 1995 | A |
5411549 | Peters | May 1995 | A |
5423829 | Pham et al. | Jun 1995 | A |
5443478 | Purdy | Aug 1995 | A |
5522822 | Phelps et al. | Jun 1996 | A |
5536252 | Imran et al. | Jul 1996 | A |
5582619 | Ken | Dec 1996 | A |
5603722 | Phan et al. | Feb 1997 | A |
5624449 | Pham et al. | Apr 1997 | A |
5624461 | Mariant | Apr 1997 | A |
5624685 | Takahashi et al. | Apr 1997 | A |
5639277 | Mariant et al. | Jun 1997 | A |
5645559 | Hachtman et al. | Jul 1997 | A |
5649949 | Wallace et al. | Jul 1997 | A |
5690666 | Berenstein et al. | Nov 1997 | A |
5690667 | Gia | Nov 1997 | A |
5693088 | Lazarus | Dec 1997 | A |
5702361 | Evans et al. | Dec 1997 | A |
5718711 | Berenstein et al. | Feb 1998 | A |
5723004 | Dereume et al. | Mar 1998 | A |
5733294 | Forber et al. | Mar 1998 | A |
5733329 | Wallace et al. | Mar 1998 | A |
5743905 | Eder et al. | Apr 1998 | A |
5749891 | Ken et al. | May 1998 | A |
5749894 | Engelson | May 1998 | A |
5766160 | Samson et al. | Jun 1998 | A |
5766219 | Horton | Jun 1998 | A |
5769882 | Fogarty et al. | Jun 1998 | A |
5769884 | Solovay | Jun 1998 | A |
5776097 | Massoud | Jul 1998 | A |
5785679 | Abolfathi et al. | Jul 1998 | A |
5795331 | Cragg et al. | Aug 1998 | A |
5800453 | Gia | Sep 1998 | A |
5800455 | Palermo et al. | Sep 1998 | A |
5826587 | Berenstein et al. | Oct 1998 | A |
5833657 | Reinhardt et al. | Nov 1998 | A |
5833705 | Ken et al. | Nov 1998 | A |
5836966 | St. Germain | Nov 1998 | A |
5853418 | Ken et al. | Dec 1998 | A |
5868780 | Lashinski et al. | Feb 1999 | A |
5873907 | Frantzen | Feb 1999 | A |
5888546 | Ji et al. | Mar 1999 | A |
5891130 | Palermo et al. | Apr 1999 | A |
5894022 | Ji et al. | Apr 1999 | A |
5911731 | Pham et al. | Jun 1999 | A |
5916235 | Guglielmi | Jun 1999 | A |
5922019 | Hankh et al. | Jul 1999 | A |
5925059 | Palermo et al. | Jul 1999 | A |
5928260 | Chin et al. | Jul 1999 | A |
5935145 | Villar et al. | Aug 1999 | A |
5935148 | Villar et al. | Aug 1999 | A |
5938697 | Killion et al. | Aug 1999 | A |
5941249 | Maynard | Aug 1999 | A |
5941888 | Wallace et al. | Aug 1999 | A |
5948018 | Dereume et al. | Sep 1999 | A |
5951599 | McCrory | Sep 1999 | A |
5957948 | Mariant | Sep 1999 | A |
5957975 | Lafont et al. | Sep 1999 | A |
5964797 | Ho | Oct 1999 | A |
5980514 | Kupiecki et al. | Nov 1999 | A |
6004338 | Ken et al. | Dec 1999 | A |
6007573 | Wallace et al. | Dec 1999 | A |
6013084 | Ken et al. | Jan 2000 | A |
6015424 | Rosenbluth et al. | Jan 2000 | A |
6015433 | Roth | Jan 2000 | A |
6017977 | Evans et al. | Jan 2000 | A |
6024754 | Engelson | Feb 2000 | A |
6024765 | Wallace et al. | Feb 2000 | A |
6027526 | Limon et al. | Feb 2000 | A |
6033423 | Ken et al. | Mar 2000 | A |
6036720 | Abrams et al. | Mar 2000 | A |
6063070 | Eder | May 2000 | A |
6063104 | Villar et al. | May 2000 | A |
6063111 | Hieshima et al. | May 2000 | A |
6071298 | Lashinski et al. | Jun 2000 | A |
6074407 | Levine et al. | Jun 2000 | A |
6086610 | Duerig et al. | Jul 2000 | A |
6093199 | Brown et al. | Jul 2000 | A |
6096021 | Helm et al. | Aug 2000 | A |
6096034 | Kupiecki et al. | Aug 2000 | A |
6096175 | Roth | Aug 2000 | A |
6099546 | Gia | Aug 2000 | A |
6099559 | Nolting | Aug 2000 | A |
6123712 | Di Caprio et al. | Sep 2000 | A |
6123714 | Gia et al. | Sep 2000 | A |
6136011 | Stambaugh | Oct 2000 | A |
6139564 | Teoh | Oct 2000 | A |
6140452 | Felt et al. | Oct 2000 | A |
6143007 | Mariant et al. | Nov 2000 | A |
6149681 | Houser et al. | Nov 2000 | A |
6159165 | Ferrera et al. | Dec 2000 | A |
6159238 | Killion et al. | Dec 2000 | A |
6165193 | Greene et al. | Dec 2000 | A |
6165212 | Dereume et al. | Dec 2000 | A |
6168592 | Kupiecki et al. | Jan 2001 | B1 |
6168615 | Ken et al. | Jan 2001 | B1 |
6168622 | Mazzocchi | Jan 2001 | B1 |
6187027 | Mariant et al. | Feb 2001 | B1 |
6190406 | Duerig et al. | Feb 2001 | B1 |
6193728 | Ken et al. | Feb 2001 | B1 |
6210429 | Vardi et al. | Apr 2001 | B1 |
6221066 | Ferrera et al. | Apr 2001 | B1 |
6231586 | Mariant | May 2001 | B1 |
6231597 | Deem et al. | May 2001 | B1 |
6238403 | Greene et al. | May 2001 | B1 |
6254592 | Samson et al. | Jul 2001 | B1 |
6258115 | Dubrul | Jul 2001 | B1 |
6258117 | Camrud et al. | Jul 2001 | B1 |
6270523 | Herweck et al. | Aug 2001 | B1 |
6273910 | Limon | Aug 2001 | B1 |
6273911 | Cox et al. | Aug 2001 | B1 |
6280457 | Wallace et al. | Aug 2001 | B1 |
6281263 | Evans et al. | Aug 2001 | B1 |
6287318 | Villar et al. | Sep 2001 | B1 |
6299619 | Greene et al. | Oct 2001 | B1 |
6306177 | Felt et al. | Oct 2001 | B1 |
6309367 | Boock | Oct 2001 | B1 |
6309413 | Dereume et al. | Oct 2001 | B1 |
6312421 | Boock | Nov 2001 | B1 |
6312463 | Rourke et al. | Nov 2001 | B1 |
6331191 | Chobotov | Dec 2001 | B1 |
6335384 | Evans et al. | Jan 2002 | B1 |
6342068 | Thompson | Jan 2002 | B1 |
6344041 | Kupiecki et al. | Feb 2002 | B1 |
6344048 | Chin et al. | Feb 2002 | B1 |
6346117 | Greenhalgh | Feb 2002 | B1 |
6350270 | Roue | Feb 2002 | B1 |
6371972 | Wallace et al. | Apr 2002 | B1 |
6375668 | Gifford et al. | Apr 2002 | B1 |
6375669 | Rosenbluth et al. | Apr 2002 | B1 |
6379373 | Sawhney et al. | Apr 2002 | B1 |
6383174 | Eder | May 2002 | B1 |
6391037 | Greenhalgh | May 2002 | B1 |
6395018 | Castaneda | May 2002 | B1 |
6398803 | Layne et al. | Jun 2002 | B1 |
6406490 | Roth | Jun 2002 | B1 |
6409721 | Wheelock et al. | Jun 2002 | B1 |
6409749 | Maynard | Jun 2002 | B1 |
6416543 | Hilaire et al. | Jul 2002 | B1 |
6419685 | Di Caprio et al. | Jul 2002 | B2 |
6423085 | Murayama et al. | Jul 2002 | B1 |
6428558 | Jones et al. | Aug 2002 | B1 |
6432128 | Wallace et al. | Aug 2002 | B1 |
6454738 | Tran et al. | Sep 2002 | B1 |
6454780 | Wallace | Sep 2002 | B1 |
6458119 | Berenstein et al. | Oct 2002 | B1 |
6463317 | Kucharczyk et al. | Oct 2002 | B1 |
6468302 | Cox et al. | Oct 2002 | B2 |
6471672 | Brown et al. | Oct 2002 | B1 |
6475233 | Trozera | Nov 2002 | B2 |
6475236 | Roubin et al. | Nov 2002 | B1 |
6485509 | Killion et al. | Nov 2002 | B2 |
6485510 | Camrud et al. | Nov 2002 | B1 |
6497722 | Von Oepen et al. | Dec 2002 | B1 |
6500190 | Greene et al. | Dec 2002 | B2 |
6506201 | Di Caprio et al. | Jan 2003 | B2 |
6506204 | Mazzocchi | Jan 2003 | B2 |
6511468 | Cragg et al. | Jan 2003 | B1 |
6511505 | Cox et al. | Jan 2003 | B2 |
6520985 | Burpee et al. | Feb 2003 | B1 |
6520987 | Plante | Feb 2003 | B1 |
6527919 | Roth | Mar 2003 | B1 |
6533801 | Wallace et al. | Mar 2003 | B2 |
6547804 | Porter et al. | Apr 2003 | B2 |
6551305 | Ferrera et al. | Apr 2003 | B2 |
6558414 | Layne | May 2003 | B2 |
6569190 | Whalen et al. | May 2003 | B2 |
6569193 | Cox et al. | May 2003 | B1 |
6579305 | Lashinski | Jun 2003 | B1 |
6579314 | Lombardi et al. | Jun 2003 | B1 |
6585748 | Jeffree | Jul 2003 | B1 |
6585753 | Eder et al. | Jul 2003 | B2 |
6585758 | Chouinard et al. | Jul 2003 | B1 |
6589230 | Gia et al. | Jul 2003 | B2 |
6599316 | Vardi et al. | Jul 2003 | B2 |
6602261 | Greene et al. | Aug 2003 | B2 |
6602269 | Wallace et al. | Aug 2003 | B2 |
6602284 | Cox et al. | Aug 2003 | B2 |
6603994 | Wallace et al. | Aug 2003 | B2 |
6605056 | Eidenschink et al. | Aug 2003 | B2 |
6605101 | Schaefer et al. | Aug 2003 | B1 |
6605111 | Bose et al. | Aug 2003 | B2 |
6613074 | Mitelberg et al. | Sep 2003 | B1 |
6616617 | Ferrera et al. | Sep 2003 | B1 |
6623493 | Wallace et al. | Sep 2003 | B2 |
6629947 | Sahatjian et al. | Oct 2003 | B1 |
6645237 | Klumb et al. | Nov 2003 | B2 |
6652576 | Stalker | Nov 2003 | B1 |
6656214 | Fogarty et al. | Dec 2003 | B1 |
6660020 | Wallace et al. | Dec 2003 | B2 |
6660032 | Klumb et al. | Dec 2003 | B2 |
6669719 | Wallace et al. | Dec 2003 | B2 |
6669723 | Killion et al. | Dec 2003 | B2 |
6673103 | Golds et al. | Jan 2004 | B1 |
6676701 | Rourke et al. | Jan 2004 | B2 |
6689148 | Sawhney et al. | Feb 2004 | B2 |
6699277 | Freidberg et al. | Mar 2004 | B1 |
6719783 | Lentz et al. | Apr 2004 | B2 |
6723108 | Jones et al. | Apr 2004 | B1 |
6746468 | Sepetka et al. | Jun 2004 | B1 |
6746475 | Rivelli | Jun 2004 | B1 |
6770087 | Layne et al. | Aug 2004 | B2 |
6780196 | Chin et al. | Aug 2004 | B2 |
6786920 | Shannon et al. | Sep 2004 | B2 |
6790225 | Shannon et al. | Sep 2004 | B1 |
6796997 | Penn et al. | Sep 2004 | B1 |
6802851 | Jones et al. | Oct 2004 | B2 |
6811560 | Jones et al. | Nov 2004 | B2 |
6814754 | Greenhalgh | Nov 2004 | B2 |
6818018 | Sawhney | Nov 2004 | B1 |
6833003 | Jones et al. | Dec 2004 | B2 |
6835203 | Vardi et al. | Dec 2004 | B1 |
6855153 | Saadat | Feb 2005 | B2 |
6855154 | Abdel-Gawwad | Feb 2005 | B2 |
6860899 | Rivelli | Mar 2005 | B1 |
6899730 | Rivelli | May 2005 | B1 |
6913618 | Denardo et al. | Jul 2005 | B2 |
6916337 | Roth | Jul 2005 | B2 |
6929658 | Freidberg et al. | Aug 2005 | B1 |
6958061 | Truckai et al. | Oct 2005 | B2 |
6962602 | Vardi et al. | Nov 2005 | B2 |
6964657 | Cragg et al. | Nov 2005 | B2 |
6969401 | Marotta et al. | Nov 2005 | B1 |
6979344 | Jones et al. | Dec 2005 | B2 |
6984240 | Ken et al. | Jan 2006 | B1 |
6994721 | Israel | Feb 2006 | B2 |
7001422 | Escamilla et al. | Feb 2006 | B2 |
7014645 | Greene et al. | Mar 2006 | B2 |
7029486 | Schaefer et al. | Apr 2006 | B2 |
7029487 | Greene et al. | Apr 2006 | B2 |
7033374 | Schaefer et al. | Apr 2006 | B2 |
7033385 | Eder et al. | Apr 2006 | B2 |
7037327 | Salmon et al. | May 2006 | B2 |
7037330 | Rivelli et al. | May 2006 | B1 |
7041129 | Rourke et al. | May 2006 | B2 |
7052510 | Richter | May 2006 | B1 |
7052513 | Thompson | May 2006 | B2 |
7060091 | Killion et al. | Jun 2006 | B2 |
7070609 | West | Jul 2006 | B2 |
7081129 | Chobotov | Jul 2006 | B2 |
7083632 | Avellanet et al. | Aug 2006 | B2 |
7083640 | Lombardi et al. | Aug 2006 | B2 |
7083643 | Whalen et al. | Aug 2006 | B2 |
7112216 | Gregorich | Sep 2006 | B2 |
7118656 | Roth | Oct 2006 | B2 |
7128736 | Abrams et al. | Oct 2006 | B1 |
7137993 | Acosta et al. | Nov 2006 | B2 |
7141063 | White et al. | Nov 2006 | B2 |
7147655 | Chermoni | Dec 2006 | B2 |
7147659 | Jones | Dec 2006 | B2 |
7147660 | Chobotov et al. | Dec 2006 | B2 |
7147661 | Chobotov et al. | Dec 2006 | B2 |
7153323 | Teoh et al. | Dec 2006 | B1 |
7156871 | Jones et al. | Jan 2007 | B2 |
7182744 | Yamasaki et al. | Feb 2007 | B2 |
7186263 | Golds et al. | Mar 2007 | B2 |
7195636 | Avellanet et al. | Mar 2007 | B2 |
7195648 | Jones et al. | Mar 2007 | B2 |
7201762 | Greene et al. | Apr 2007 | B2 |
7211109 | Thompson | May 2007 | B2 |
7220270 | Sawhney et al. | May 2007 | B2 |
7226475 | Lenz et al. | Jun 2007 | B2 |
7229461 | Chin et al. | Jun 2007 | B2 |
7231260 | Wallace et al. | Jun 2007 | B2 |
7232461 | Ramer | Jun 2007 | B2 |
7235098 | Palmaz | Jun 2007 | B2 |
7238194 | Monstadt et al. | Jul 2007 | B2 |
7241301 | Thramann et al. | Jul 2007 | B2 |
7241308 | Andreas et al. | Jul 2007 | B2 |
7244261 | Lorenzo et al. | Jul 2007 | B2 |
7247159 | Lorenzo et al. | Jul 2007 | B2 |
7288112 | Denardo et al. | Oct 2007 | B2 |
7294123 | Jones et al. | Nov 2007 | B2 |
7294137 | Rivelli et al. | Nov 2007 | B2 |
7294146 | Chew et al. | Nov 2007 | B2 |
7300459 | Heuser | Nov 2007 | B2 |
7300661 | Henson et al. | Nov 2007 | B2 |
7306598 | Truckai et al. | Dec 2007 | B2 |
7306622 | Jones et al. | Dec 2007 | B2 |
7306624 | Yodfat et al. | Dec 2007 | B2 |
7309351 | Escamilla et al. | Dec 2007 | B2 |
7309352 | Eder et al. | Dec 2007 | B2 |
7311861 | Lanphere et al. | Dec 2007 | B2 |
7323005 | Wallace et al. | Jan 2008 | B2 |
7326225 | Ferrera et al. | Feb 2008 | B2 |
7326236 | Andreas et al. | Feb 2008 | B2 |
7331974 | Schaefer et al. | Feb 2008 | B2 |
7338511 | Mirigian et al. | Mar 2008 | B2 |
7361367 | Henson et al. | Apr 2008 | B2 |
7374568 | Whalen et al. | May 2008 | B2 |
7384426 | Wallace et al. | Jun 2008 | B2 |
7402169 | Killion et al. | Jul 2008 | B2 |
7410482 | Murphy et al. | Aug 2008 | B2 |
7413573 | Hartley et al. | Aug 2008 | B2 |
7414038 | Kinugasa et al. | Aug 2008 | B2 |
7442382 | Henson et al. | Oct 2008 | B2 |
7449236 | Lanphere et al. | Nov 2008 | B2 |
7455753 | Roth | Nov 2008 | B2 |
7481821 | Fogarty et al. | Jan 2009 | B2 |
7483558 | Greene et al. | Jan 2009 | B2 |
7485123 | Porter | Feb 2009 | B2 |
7491214 | Greene et al. | Feb 2009 | B2 |
7491226 | Palmaz et al. | Feb 2009 | B2 |
7491229 | Eder et al. | Feb 2009 | B2 |
7520893 | Rivelli | Apr 2009 | B2 |
7537609 | Davidson et al. | May 2009 | B2 |
7547321 | Silvestri et al. | Jun 2009 | B2 |
7563270 | Gumm | Jul 2009 | B2 |
7569066 | Gerberding et al. | Aug 2009 | B2 |
7572288 | Cox | Aug 2009 | B2 |
7572290 | Yodfat et al. | Aug 2009 | B2 |
7588597 | Frid | Sep 2009 | B2 |
7588780 | Buiser et al. | Sep 2009 | B2 |
7588825 | Bell et al. | Sep 2009 | B2 |
7608088 | Jones et al. | Oct 2009 | B2 |
7611530 | Pomeranz et al. | Nov 2009 | B2 |
7615071 | Chobotov | Nov 2009 | B2 |
7621928 | Thramann et al. | Nov 2009 | B2 |
7641680 | Palmaz et al. | Jan 2010 | B2 |
7645298 | Hartley et al. | Jan 2010 | B2 |
7651525 | Dolan | Jan 2010 | B2 |
7666220 | Evans et al. | Feb 2010 | B2 |
7666333 | Lanphere et al. | Feb 2010 | B2 |
7691124 | Balgobin | Apr 2010 | B2 |
7695484 | Wallace et al. | Apr 2010 | B2 |
7695488 | Berenstein et al. | Apr 2010 | B2 |
7695507 | Rivelli et al. | Apr 2010 | B2 |
7695509 | Rourke et al. | Apr 2010 | B2 |
7704274 | Boyle et al. | Apr 2010 | B2 |
7708754 | Balgobin et al. | May 2010 | B2 |
7708755 | Davis et al. | May 2010 | B2 |
7713264 | Murphy et al. | May 2010 | B2 |
7736671 | DiCarlo et al. | Jun 2010 | B2 |
7744610 | Hausen | Jun 2010 | B2 |
7744652 | Morsi | Jun 2010 | B2 |
7749242 | Tran et al. | Jul 2010 | B2 |
7758892 | Chen et al. | Jul 2010 | B1 |
7763011 | Ortiz et al. | Jul 2010 | B2 |
7766933 | Davis et al. | Aug 2010 | B2 |
7766955 | Vardi et al. | Aug 2010 | B2 |
7769603 | Jung et al. | Aug 2010 | B2 |
7776079 | Gumm | Aug 2010 | B2 |
7780645 | Jones | Aug 2010 | B2 |
7780719 | Killion et al. | Aug 2010 | B2 |
7799047 | Greene et al. | Sep 2010 | B2 |
7799052 | Balgobin et al. | Sep 2010 | B2 |
7803179 | Denison | Sep 2010 | B2 |
7803180 | Burpee et al. | Sep 2010 | B2 |
7811300 | Feller et al. | Oct 2010 | B2 |
7811305 | Balgobin et al. | Oct 2010 | B2 |
7818084 | Boyden et al. | Oct 2010 | B2 |
7819891 | Balgobin et al. | Oct 2010 | B2 |
7819892 | Balgobin et al. | Oct 2010 | B2 |
7842054 | Greene et al. | Nov 2010 | B2 |
7842377 | Lanphere et al. | Nov 2010 | B2 |
7850725 | Vardi et al. | Dec 2010 | B2 |
7857843 | Henderson | Dec 2010 | B2 |
7862608 | Hogendijk et al. | Jan 2011 | B2 |
7875044 | Feller et al. | Jan 2011 | B2 |
7883526 | Jones et al. | Feb 2011 | B2 |
7892273 | George et al. | Feb 2011 | B2 |
7892279 | Davidson et al. | Feb 2011 | B2 |
7896899 | Patterson et al. | Mar 2011 | B2 |
7901445 | Wallace et al. | Mar 2011 | B2 |
7905913 | Chew et al. | Mar 2011 | B2 |
7914574 | Schmid et al. | Mar 2011 | B2 |
7914639 | Layne et al. | Mar 2011 | B2 |
7918881 | Andreas et al. | Apr 2011 | B2 |
7922755 | Acosta et al. | Apr 2011 | B2 |
7935142 | Gregorich | May 2011 | B2 |
7938845 | Aganon et al. | May 2011 | B2 |
7942925 | Yodfat et al. | May 2011 | B2 |
7947071 | Schmid et al. | May 2011 | B2 |
7955382 | Flanagan et al. | Jun 2011 | B2 |
7959662 | Erbel et al. | Jun 2011 | B2 |
7963987 | Melsheimer et al. | Jun 2011 | B2 |
7976527 | Cragg et al. | Jul 2011 | B2 |
7976823 | Lanphere et al. | Jul 2011 | B2 |
7985238 | Balgobin et al. | Jul 2011 | B2 |
7988721 | Morris et al. | Aug 2011 | B2 |
7993364 | Morsi | Aug 2011 | B2 |
8002789 | Ramzipoor et al. | Aug 2011 | B2 |
8003180 | Goffena et al. | Aug 2011 | B2 |
8007529 | Yan | Aug 2011 | B2 |
8012192 | Eidenschink et al. | Sep 2011 | B2 |
8012197 | Bashiri et al. | Sep 2011 | B2 |
8016853 | Griffen et al. | Sep 2011 | B2 |
8016870 | Chew et al. | Sep 2011 | B2 |
8016871 | Chew et al. | Sep 2011 | B2 |
8016876 | Gregorich et al. | Sep 2011 | B2 |
8016878 | Meyer et al. | Sep 2011 | B2 |
8019413 | Ferren et al. | Sep 2011 | B2 |
8021416 | Abrams | Sep 2011 | B2 |
8024036 | Ferren et al. | Sep 2011 | B2 |
8034073 | Davis et al. | Oct 2011 | B2 |
8038706 | Eidenschink et al. | Oct 2011 | B2 |
8038708 | Case et al. | Oct 2011 | B2 |
8048140 | Purdy | Nov 2011 | B2 |
8052736 | Doig et al. | Nov 2011 | B2 |
8057495 | Pal et al. | Nov 2011 | B2 |
8062379 | Morsi | Nov 2011 | B2 |
8066036 | Monetti et al. | Nov 2011 | B2 |
8067071 | Farnsworth et al. | Nov 2011 | B2 |
8070792 | Gregorich et al. | Dec 2011 | B2 |
8075585 | Lee et al. | Dec 2011 | B2 |
8095382 | Boyden et al. | Jan 2012 | B2 |
8100960 | Bruszewski | Jan 2012 | B2 |
8133256 | Wilson et al. | Mar 2012 | B2 |
8142456 | Rosqueta et al. | Mar 2012 | B2 |
8147534 | Berez et al. | Apr 2012 | B2 |
8147537 | Boyden et al. | Apr 2012 | B2 |
8163003 | Boyden et al. | Apr 2012 | B2 |
8172862 | Wallace et al. | May 2012 | B2 |
8172895 | Anderson et al. | May 2012 | B2 |
8187315 | Clauson et al. | May 2012 | B1 |
8202292 | Kellett | Jun 2012 | B2 |
8211141 | Davis et al. | Jul 2012 | B2 |
8211160 | Garrison et al. | Jul 2012 | B2 |
8221447 | Solar et al. | Jul 2012 | B2 |
8226660 | Teoh et al. | Jul 2012 | B2 |
8226706 | Hartley et al. | Jul 2012 | B2 |
8236042 | Berez et al. | Aug 2012 | B2 |
8246672 | Osborne | Aug 2012 | B2 |
8252040 | Cox | Aug 2012 | B2 |
8257421 | Berez et al. | Sep 2012 | B2 |
8257431 | Henderson et al. | Sep 2012 | B2 |
8257684 | Covalin et al. | Sep 2012 | B2 |
8262607 | Porter | Sep 2012 | B2 |
8262686 | Fogarty et al. | Sep 2012 | B2 |
8267923 | Murphy et al. | Sep 2012 | B2 |
8267955 | Patterson et al. | Sep 2012 | B2 |
8267985 | Garcia et al. | Sep 2012 | B2 |
8267986 | Berez et al. | Sep 2012 | B2 |
8273100 | Martinez | Sep 2012 | B2 |
8273101 | Garcia et al. | Sep 2012 | B2 |
8277500 | Schmid et al. | Oct 2012 | B2 |
8282679 | Denison | Oct 2012 | B2 |
8292914 | Morsi | Oct 2012 | B2 |
8292944 | Schmid et al. | Oct 2012 | B2 |
8308751 | Gerberding | Nov 2012 | B2 |
8313504 | Do et al. | Nov 2012 | B2 |
8323306 | Schaefer et al. | Dec 2012 | B2 |
8328860 | Strauss et al. | Dec 2012 | B2 |
8353943 | Kuppurathanam et al. | Jan 2013 | B2 |
8357178 | Grandfield et al. | Jan 2013 | B2 |
8357179 | Grandfield et al. | Jan 2013 | B2 |
8357180 | Feller et al. | Jan 2013 | B2 |
8361104 | Jones et al. | Jan 2013 | B2 |
8361106 | Solar et al. | Jan 2013 | B2 |
8372062 | Murphy et al. | Feb 2013 | B2 |
8372114 | Hines | Feb 2013 | B2 |
8377091 | Cruise et al. | Feb 2013 | B2 |
8377112 | Griffin et al. | Feb 2013 | B2 |
8377241 | Farnsworth et al. | Feb 2013 | B2 |
8382825 | Garcia et al. | Feb 2013 | B2 |
8388650 | Gerberding et al. | Mar 2013 | B2 |
8388677 | Herrmann | Mar 2013 | B2 |
8394136 | Hartley et al. | Mar 2013 | B2 |
8398670 | Amplatz et al. | Mar 2013 | B2 |
8398701 | Berez et al. | Mar 2013 | B2 |
8409267 | Berez et al. | Apr 2013 | B2 |
8409269 | Berez et al. | Apr 2013 | B2 |
8414637 | Chouinard | Apr 2013 | B2 |
8419787 | Yodfat et al. | Apr 2013 | B2 |
8425541 | Masters et al. | Apr 2013 | B2 |
8425542 | Moftakhar et al. | Apr 2013 | B2 |
8425548 | Connor | Apr 2013 | B2 |
8430922 | Jung et al. | Apr 2013 | B2 |
8439942 | Moran et al. | May 2013 | B2 |
8444667 | Porter | May 2013 | B2 |
8444668 | Jones et al. | May 2013 | B2 |
8444686 | Holman et al. | May 2013 | B2 |
8449532 | Murphy et al. | May 2013 | B2 |
8449592 | Wilson et al. | May 2013 | B2 |
8454649 | Cragg et al. | Jun 2013 | B2 |
8460240 | Towler | Jun 2013 | B2 |
8470013 | Duggal et al. | Jun 2013 | B2 |
8470035 | Cruise et al. | Jun 2013 | B2 |
8473030 | Greenan et al. | Jun 2013 | B2 |
8475517 | Jung et al. | Jul 2013 | B2 |
8478437 | Boyden et al. | Jul 2013 | B2 |
8480727 | Clarke | Jul 2013 | B2 |
8486101 | Tran et al. | Jul 2013 | B2 |
8491459 | Yun | Jul 2013 | B2 |
8491646 | Schreck | Jul 2013 | B2 |
8500788 | Berez et al. | Aug 2013 | B2 |
8506618 | Chouinard et al. | Aug 2013 | B2 |
8506619 | Ortiz et al. | Aug 2013 | B2 |
8512219 | Ferren et al. | Aug 2013 | B2 |
8512395 | Meyer et al. | Aug 2013 | B2 |
8523934 | Purdy | Sep 2013 | B2 |
8529556 | Murphy et al. | Sep 2013 | B2 |
8529596 | Grandfield et al. | Sep 2013 | B2 |
8529614 | Berez et al. | Sep 2013 | B2 |
8529616 | Boyle et al. | Sep 2013 | B2 |
8529619 | Abrams | Sep 2013 | B2 |
8535367 | Kim et al. | Sep 2013 | B2 |
8535590 | Milner et al. | Sep 2013 | B2 |
8550344 | Jung et al. | Oct 2013 | B2 |
8551155 | Jung et al. | Oct 2013 | B2 |
8556953 | Berez et al. | Oct 2013 | B2 |
8562636 | Fogarty et al. | Oct 2013 | B2 |
8562667 | Cox | Oct 2013 | B2 |
8577693 | Jung et al. | Nov 2013 | B2 |
8597320 | Sepetka et al. | Dec 2013 | B2 |
8597321 | Monstadt et al. | Dec 2013 | B2 |
8597323 | Plaza et al. | Dec 2013 | B1 |
8597342 | McKinsey et al. | Dec 2013 | B2 |
8597745 | Farnsworth et al. | Dec 2013 | B2 |
8617132 | Golzarian et al. | Dec 2013 | B2 |
8623071 | Lundkvist et al. | Jan 2014 | B2 |
8636760 | Garcia et al. | Jan 2014 | B2 |
8647377 | Kim et al. | Feb 2014 | B2 |
8657865 | Gumm | Feb 2014 | B2 |
8663309 | Chobotov | Mar 2014 | B2 |
8668716 | Hines | Mar 2014 | B2 |
8668717 | Hines | Mar 2014 | B2 |
8671815 | Hancock et al. | Mar 2014 | B2 |
8696701 | Becking et al. | Apr 2014 | B2 |
8709062 | Dusbabek et al. | Apr 2014 | B2 |
8709065 | Chobotov | Apr 2014 | B2 |
8715312 | Burke et al. | May 2014 | B2 |
8715317 | Janardhan et al. | May 2014 | B1 |
8715336 | Chu et al. | May 2014 | B2 |
8721706 | Jung et al. | May 2014 | B2 |
8728094 | Roorda et al. | May 2014 | B2 |
8728145 | Chuter et al. | May 2014 | B2 |
8728146 | Gregorich et al. | May 2014 | B2 |
8734502 | Orr | May 2014 | B2 |
8740966 | Brocker et al. | Jun 2014 | B2 |
8747430 | Porter | Jun 2014 | B2 |
8747432 | Janardhan et al. | Jun 2014 | B1 |
8747455 | Greenberg | Jun 2014 | B2 |
8747597 | Rosqueta et al. | Jun 2014 | B2 |
8753371 | Janardhan et al. | Jun 2014 | B1 |
8764788 | Martinez | Jul 2014 | B2 |
8769796 | Bourang et al. | Jul 2014 | B2 |
8771294 | Sepetka et al. | Jul 2014 | B2 |
8771341 | Strauss et al. | Jul 2014 | B2 |
8771342 | Vardi | Jul 2014 | B2 |
8784446 | Janardhan et al. | Jul 2014 | B1 |
8784475 | Martinson et al. | Jul 2014 | B2 |
8784477 | Bregulla et al. | Jul 2014 | B2 |
8795345 | Grandfield et al. | Aug 2014 | B2 |
8795346 | Alkhatib | Aug 2014 | B2 |
8795347 | Bourang et al. | Aug 2014 | B2 |
8801772 | Shobayashi et al. | Aug 2014 | B2 |
8808347 | Bourang et al. | Aug 2014 | B2 |
8808361 | Strauss et al. | Aug 2014 | B2 |
8813625 | Janardhan et al. | Aug 2014 | B1 |
8821564 | Schreck et al. | Sep 2014 | B2 |
8828071 | Bourang et al. | Sep 2014 | B2 |
8840867 | Sophie et al. | Sep 2014 | B2 |
8845679 | Janardhan et al. | Sep 2014 | B1 |
20010000797 | Mazzocchi | May 2001 | A1 |
20010001835 | Greene et al. | May 2001 | A1 |
20010009996 | Ferrera et al. | Jul 2001 | A1 |
20010016766 | Vardi et al. | Aug 2001 | A1 |
20010037137 | Vardi et al. | Nov 2001 | A1 |
20010056281 | Wallace et al. | Dec 2001 | A1 |
20020002382 | Wallace et al. | Jan 2002 | A1 |
20020018752 | Krall et al. | Feb 2002 | A1 |
20020042628 | Chin et al. | Apr 2002 | A1 |
20020058962 | Wallace et al. | May 2002 | A1 |
20020082620 | Lee | Jun 2002 | A1 |
20020082636 | Sawhney et al. | Jun 2002 | A1 |
20020087077 | Wallace et al. | Jul 2002 | A1 |
20020107534 | Schaefer et al. | Aug 2002 | A1 |
20020116047 | Vardi et al. | Aug 2002 | A1 |
20020120276 | Greene et al. | Aug 2002 | A1 |
20020128671 | Wallace et al. | Sep 2002 | A1 |
20020133190 | Horton et al. | Sep 2002 | A1 |
20020143348 | Wallace et al. | Oct 2002 | A1 |
20020151926 | Wallace et al. | Oct 2002 | A1 |
20020151965 | Roth | Oct 2002 | A1 |
20020156516 | Vardi et al. | Oct 2002 | A1 |
20020169473 | Sepetka et al. | Nov 2002 | A1 |
20020177855 | Greene et al. | Nov 2002 | A1 |
20030014007 | Eidenschink et al. | Jan 2003 | A1 |
20030014075 | Rosenbluth et al. | Jan 2003 | A1 |
20030018294 | Cox | Jan 2003 | A1 |
20030018356 | Schaefer et al. | Jan 2003 | A1 |
20030065375 | Eskuri | Apr 2003 | A1 |
20030074049 | Hoganson et al. | Apr 2003 | A1 |
20030074056 | Killion et al. | Apr 2003 | A1 |
20030083676 | Wallace | May 2003 | A1 |
20030083737 | Greene et al. | May 2003 | A1 |
20030088311 | Greene et al. | May 2003 | A1 |
20030093097 | Avellanet et al. | May 2003 | A1 |
20030093108 | Avellanet et al. | May 2003 | A1 |
20030093111 | Ken et al. | May 2003 | A1 |
20030100945 | Yodfat et al. | May 2003 | A1 |
20030109917 | Rudin et al. | Jun 2003 | A1 |
20030130689 | Wallace et al. | Jul 2003 | A1 |
20030135264 | Whalen et al. | Jul 2003 | A1 |
20030139802 | Wulfman | Jul 2003 | A1 |
20030159920 | Roth | Aug 2003 | A1 |
20030181927 | Wallace | Sep 2003 | A1 |
20030187473 | Berenstein et al. | Oct 2003 | A1 |
20030195553 | Wallace et al. | Oct 2003 | A1 |
20030195606 | Davidson et al. | Oct 2003 | A1 |
20030223955 | Whalen et al. | Dec 2003 | A1 |
20040002752 | Griffin et al. | Jan 2004 | A1 |
20040015227 | Vardi et al. | Jan 2004 | A1 |
20040045554 | Schaefer et al. | Mar 2004 | A1 |
20040059370 | Greene et al. | Mar 2004 | A1 |
20040091543 | Bell et al. | May 2004 | A1 |
20040093014 | Ho et al. | May 2004 | A1 |
20040098027 | Teoh et al. | May 2004 | A1 |
20040098028 | Martinez | May 2004 | A1 |
20040111112 | Hoffmann | Jun 2004 | A1 |
20040111142 | Rourke et al. | Jun 2004 | A1 |
20040115164 | Pierce et al. | Jun 2004 | A1 |
20040158282 | Jones et al. | Aug 2004 | A1 |
20040161451 | Pierce et al. | Aug 2004 | A1 |
20040181253 | Sepetka et al. | Sep 2004 | A1 |
20040186551 | Kao et al. | Sep 2004 | A1 |
20040193246 | Ferrera | Sep 2004 | A1 |
20040210249 | Fogarty et al. | Oct 2004 | A1 |
20040215331 | Chew et al. | Oct 2004 | A1 |
20040220663 | Rivelli, Jr. | Nov 2004 | A1 |
20040243168 | Ferrera et al. | Dec 2004 | A1 |
20040243216 | Gregorich | Dec 2004 | A1 |
20040249435 | Andreas et al. | Dec 2004 | A1 |
20040249439 | Richter et al. | Dec 2004 | A1 |
20040260384 | Allen | Dec 2004 | A1 |
20050004660 | Rosenbluth et al. | Jan 2005 | A1 |
20050010281 | Yodfat et al. | Jan 2005 | A1 |
20050015110 | Fogarty et al. | Jan 2005 | A1 |
20050021077 | Chin et al. | Jan 2005 | A1 |
20050033349 | Jones et al. | Feb 2005 | A1 |
20050033350 | Ken et al. | Feb 2005 | A1 |
20050065592 | Holzer | Mar 2005 | A1 |
20050075405 | Wilson et al. | Apr 2005 | A1 |
20050080445 | Sawhney et al. | Apr 2005 | A1 |
20050090888 | Hines et al. | Apr 2005 | A1 |
20050095428 | Dicarlo et al. | May 2005 | A1 |
20050096728 | Ramer | May 2005 | A1 |
20050107863 | Brown | May 2005 | A1 |
20050119687 | Dacey et al. | Jun 2005 | A1 |
20050131516 | Greenhalgh | Jun 2005 | A1 |
20050131518 | Hartley et al. | Jun 2005 | A1 |
20050133046 | Becker et al. | Jun 2005 | A1 |
20050149159 | Andreas et al. | Jul 2005 | A1 |
20050149164 | Rivelli | Jul 2005 | A1 |
20050171572 | Martinez | Aug 2005 | A1 |
20050171597 | Boatman et al. | Aug 2005 | A1 |
20050192618 | Porter | Sep 2005 | A1 |
20050192621 | Wallace et al. | Sep 2005 | A1 |
20050192661 | Griffen et al. | Sep 2005 | A1 |
20050209674 | Kutscher et al. | Sep 2005 | A1 |
20050228434 | Amplatz et al. | Oct 2005 | A1 |
20050251247 | Roth | Nov 2005 | A1 |
20050267510 | Razack | Dec 2005 | A1 |
20050267568 | Berez et al. | Dec 2005 | A1 |
20050277978 | Greenhalgh | Dec 2005 | A1 |
20050283220 | Gobran et al. | Dec 2005 | A1 |
20060036045 | Wilson et al. | Feb 2006 | A1 |
20060036281 | Patterson et al. | Feb 2006 | A1 |
20060052816 | Bates et al. | Mar 2006 | A1 |
20060058834 | Do et al. | Mar 2006 | A1 |
20060079923 | Chhabra et al. | Apr 2006 | A1 |
20060085061 | Vardi et al. | Apr 2006 | A1 |
20060116709 | Sepetka et al. | Jun 2006 | A1 |
20060116712 | Sepetka et al. | Jun 2006 | A1 |
20060116713 | Sepetka et al. | Jun 2006 | A1 |
20060136033 | Hermann et al. | Jun 2006 | A1 |
20060149299 | Greene et al. | Jul 2006 | A1 |
20060155323 | Porter et al. | Jul 2006 | A1 |
20060155367 | Hines | Jul 2006 | A1 |
20060184195 | Schaefer et al. | Aug 2006 | A1 |
20060184196 | Schaefer et al. | Aug 2006 | A1 |
20060206196 | Porter | Sep 2006 | A1 |
20060206200 | Garcia et al. | Sep 2006 | A1 |
20060206201 | Garcia et al. | Sep 2006 | A1 |
20060224230 | Rivelli et al. | Oct 2006 | A1 |
20060229714 | Lombardi et al. | Oct 2006 | A1 |
20060235464 | Avellanet et al. | Oct 2006 | A1 |
20060241690 | Amplatz et al. | Oct 2006 | A1 |
20060241740 | Vardi et al. | Oct 2006 | A1 |
20060251695 | Henson et al. | Nov 2006 | A1 |
20060251700 | Henson et al. | Nov 2006 | A1 |
20060271149 | Berez et al. | Nov 2006 | A1 |
20060271153 | Garcia et al. | Nov 2006 | A1 |
20060276831 | Porter et al. | Dec 2006 | A1 |
20060292206 | Kim et al. | Dec 2006 | A1 |
20070016233 | Ferrera et al. | Jan 2007 | A1 |
20070021816 | Rudin | Jan 2007 | A1 |
20070031584 | Roth | Feb 2007 | A1 |
20070032855 | Davidson et al. | Feb 2007 | A1 |
20070050008 | Kim et al. | Mar 2007 | A1 |
20070055355 | Kim et al. | Mar 2007 | A1 |
20070060994 | Gobran et al. | Mar 2007 | A1 |
20070061005 | Kim et al. | Mar 2007 | A1 |
20070067015 | Jones et al. | Mar 2007 | A1 |
20070083257 | Pal et al. | Apr 2007 | A1 |
20070088368 | Acosta et al. | Apr 2007 | A1 |
20070088387 | Eskridge et al. | Apr 2007 | A1 |
20070100301 | Gumm | May 2007 | A1 |
20070106311 | Wallace et al. | May 2007 | A1 |
20070129786 | Beach et al. | Jun 2007 | A1 |
20070135907 | Wilson et al. | Jun 2007 | A1 |
20070150041 | Evans et al. | Jun 2007 | A1 |
20070150045 | Ferrera | Jun 2007 | A1 |
20070167747 | Borgert et al. | Jul 2007 | A1 |
20070175536 | Monetti et al. | Aug 2007 | A1 |
20070176333 | Greene et al. | Aug 2007 | A1 |
20070207186 | Scanlon et al. | Sep 2007 | A1 |
20070219578 | Solar et al. | Sep 2007 | A1 |
20070219610 | Israel | Sep 2007 | A1 |
20070219619 | Dieck et al. | Sep 2007 | A1 |
20070225794 | Thramann et al. | Sep 2007 | A1 |
20070239261 | Bose et al. | Oct 2007 | A1 |
20070265656 | Amplatz et al. | Nov 2007 | A1 |
20070299464 | Cruise et al. | Dec 2007 | A1 |
20070299498 | Perez et al. | Dec 2007 | A1 |
20080004653 | Sherman et al. | Jan 2008 | A1 |
20080004692 | Henson et al. | Jan 2008 | A1 |
20080031919 | Henson et al. | Feb 2008 | A1 |
20080033341 | Grad | Feb 2008 | A1 |
20080033366 | Matson et al. | Feb 2008 | A1 |
20080039933 | Yodfat et al. | Feb 2008 | A1 |
20080097495 | Feller et al. | Apr 2008 | A1 |
20080103585 | Monstadt et al. | May 2008 | A1 |
20080114391 | Dieck et al. | May 2008 | A1 |
20080114436 | Dieck et al. | May 2008 | A1 |
20080125852 | Garrison et al. | May 2008 | A1 |
20080147100 | Wallace | Jun 2008 | A1 |
20080152686 | Henson et al. | Jun 2008 | A1 |
20080161936 | Feller et al. | Jul 2008 | A1 |
20080195137 | Alleyne et al. | Aug 2008 | A1 |
20080200945 | Amplatz et al. | Aug 2008 | A1 |
20080221600 | Dieck et al. | Sep 2008 | A1 |
20080249608 | Dave | Oct 2008 | A1 |
20080281350 | Sepetka et al. | Nov 2008 | A1 |
20080312732 | Hartley et al. | Dec 2008 | A1 |
20080319521 | Norris et al. | Dec 2008 | A1 |
20080319525 | Tieu et al. | Dec 2008 | A1 |
20080319533 | Lehe | Dec 2008 | A1 |
20090062834 | Moftakhar et al. | Mar 2009 | A1 |
20090062841 | Amplatz et al. | Mar 2009 | A1 |
20090069880 | Vonderwalde et al. | Mar 2009 | A1 |
20090082846 | Chobotov | Mar 2009 | A1 |
20090088832 | Chew et al. | Apr 2009 | A1 |
20090105748 | Fogarty et al. | Apr 2009 | A1 |
20090112249 | Miles et al. | Apr 2009 | A1 |
20090112250 | Greene et al. | Apr 2009 | A1 |
20090118761 | Masters et al. | May 2009 | A1 |
20090125053 | Ferrera et al. | May 2009 | A1 |
20090132028 | Vardi et al. | May 2009 | A1 |
20090149864 | Porter | Jun 2009 | A1 |
20090164013 | Cruise et al. | Jun 2009 | A1 |
20090171437 | Brocker et al. | Jul 2009 | A1 |
20090177268 | Lundkvist et al. | Jul 2009 | A1 |
20090192536 | Berez et al. | Jul 2009 | A1 |
20090198318 | Berez et al. | Aug 2009 | A1 |
20090227976 | Calabria et al. | Sep 2009 | A1 |
20090228029 | Lee | Sep 2009 | A1 |
20090232869 | Greene et al. | Sep 2009 | A1 |
20090248135 | Bruszewski et al. | Oct 2009 | A1 |
20090254111 | Monstadt et al. | Oct 2009 | A1 |
20090270970 | Yodfat et al. | Oct 2009 | A1 |
20090270974 | Berez et al. | Oct 2009 | A1 |
20090275974 | Marchand et al. | Nov 2009 | A1 |
20090287241 | Berez et al. | Nov 2009 | A1 |
20090287288 | Berez et al. | Nov 2009 | A1 |
20090287291 | Becking et al. | Nov 2009 | A1 |
20090287292 | Becking et al. | Nov 2009 | A1 |
20090287294 | Rosqueta et al. | Nov 2009 | A1 |
20090292348 | Berez et al. | Nov 2009 | A1 |
20090297582 | Meyer et al. | Dec 2009 | A1 |
20090299326 | Morsi | Dec 2009 | A1 |
20090299390 | Dehnad | Dec 2009 | A1 |
20090299448 | Timko et al. | Dec 2009 | A1 |
20090318941 | Sepetka et al. | Dec 2009 | A1 |
20090318947 | Garcia et al. | Dec 2009 | A1 |
20090318948 | Linder et al. | Dec 2009 | A1 |
20090318949 | Ganpath et al. | Dec 2009 | A1 |
20090319017 | Berez et al. | Dec 2009 | A1 |
20090319023 | Hildebrand et al. | Dec 2009 | A1 |
20100004671 | Gerberding et al. | Jan 2010 | A1 |
20100004726 | Hancock et al. | Jan 2010 | A1 |
20100010624 | Berez et al. | Jan 2010 | A1 |
20100016833 | Ogle et al. | Jan 2010 | A1 |
20100023105 | Levy et al. | Jan 2010 | A1 |
20100036412 | Porter et al. | Feb 2010 | A1 |
20100042200 | Richter et al. | Feb 2010 | A1 |
20100063472 | Becker et al. | Mar 2010 | A1 |
20100063531 | Rudakov et al. | Mar 2010 | A1 |
20100069948 | Veznedaroglu et al. | Mar 2010 | A1 |
20100082091 | Berez et al. | Apr 2010 | A1 |
20100094335 | Gerberding et al. | Apr 2010 | A1 |
20100106240 | Duggal et al. | Apr 2010 | A1 |
20100114302 | Tzafriri et al. | May 2010 | A1 |
20100131002 | Connor et al. | May 2010 | A1 |
20100152828 | Pakbaz et al. | Jun 2010 | A1 |
20100152834 | Hannes et al. | Jun 2010 | A1 |
20100152837 | Lundkvist et al. | Jun 2010 | A1 |
20100168781 | Berenstein et al. | Jul 2010 | A1 |
20100174301 | Wallace et al. | Jul 2010 | A1 |
20100179640 | Reith | Jul 2010 | A1 |
20100179645 | Chen et al. | Jul 2010 | A1 |
20100198250 | Ricci et al. | Aug 2010 | A1 |
20100198334 | Yodfat et al. | Aug 2010 | A1 |
20100222804 | Murphy et al. | Sep 2010 | A1 |
20100222864 | Rivelli et al. | Sep 2010 | A1 |
20100274276 | Chow et al. | Oct 2010 | A1 |
20100274346 | Chouinard et al. | Oct 2010 | A1 |
20100280452 | Chen et al. | Nov 2010 | A1 |
20100305681 | Gumm | Dec 2010 | A1 |
20100312326 | Chuter et al. | Dec 2010 | A1 |
20100318173 | Kolandaivelu et al. | Dec 2010 | A1 |
20100324660 | Denison | Dec 2010 | A1 |
20110004294 | Bialas | Jan 2011 | A1 |
20110005062 | Greene et al. | Jan 2011 | A1 |
20110009940 | Grandfield et al. | Jan 2011 | A1 |
20110009941 | Grandfield et al. | Jan 2011 | A1 |
20110009950 | Grandfield et al. | Jan 2011 | A1 |
20110022149 | Cox et al. | Jan 2011 | A1 |
20110039967 | Wilson et al. | Feb 2011 | A1 |
20110046658 | Connor et al. | Feb 2011 | A1 |
20110046716 | Parkinson et al. | Feb 2011 | A1 |
20110054511 | Henson et al. | Mar 2011 | A1 |
20110054589 | Bashiri et al. | Mar 2011 | A1 |
20110066221 | White et al. | Mar 2011 | A1 |
20110082427 | Golzarian et al. | Apr 2011 | A1 |
20110082491 | Sepetka et al. | Apr 2011 | A1 |
20110082533 | Vardi et al. | Apr 2011 | A1 |
20110089592 | Farnsworth et al. | Apr 2011 | A1 |
20110092997 | Kang | Apr 2011 | A1 |
20110098814 | Monstadt et al. | Apr 2011 | A1 |
20110118777 | Patterson et al. | May 2011 | A1 |
20110137332 | Sepetka et al. | Jun 2011 | A1 |
20110137405 | Wilson et al. | Jun 2011 | A1 |
20110144669 | Becking et al. | Jun 2011 | A1 |
20110144686 | Wilson et al. | Jun 2011 | A1 |
20110144740 | Molaei et al. | Jun 2011 | A1 |
20110152993 | Marchand et al. | Jun 2011 | A1 |
20110152996 | Acosta et al. | Jun 2011 | A1 |
20110152998 | Berez et al. | Jun 2011 | A1 |
20110166588 | Connor et al. | Jul 2011 | A1 |
20110166592 | Garcia et al. | Jul 2011 | A1 |
20110166641 | Bales et al. | Jul 2011 | A1 |
20110182998 | Reb et al. | Jul 2011 | A1 |
20110184451 | Sahl | Jul 2011 | A1 |
20110184452 | Huynh et al. | Jul 2011 | A1 |
20110184453 | Levy et al. | Jul 2011 | A1 |
20110184454 | Barry et al. | Jul 2011 | A1 |
20110184455 | Keeley et al. | Jul 2011 | A1 |
20110184456 | Grandfield et al. | Jul 2011 | A1 |
20110196413 | Wallace et al. | Aug 2011 | A1 |
20110202085 | Loganathan et al. | Aug 2011 | A1 |
20110208227 | Becking | Aug 2011 | A1 |
20110213406 | Aganon et al. | Sep 2011 | A1 |
20110224776 | Sepetka et al. | Sep 2011 | A1 |
20110230957 | Bonsignore et al. | Sep 2011 | A1 |
20110238105 | Gelbart et al. | Sep 2011 | A1 |
20110245862 | Dieck et al. | Oct 2011 | A1 |
20110245863 | Martinez | Oct 2011 | A1 |
20110264192 | Hartley et al. | Oct 2011 | A1 |
20110265943 | Rosqueta et al. | Nov 2011 | A1 |
20110276071 | Connor et al. | Nov 2011 | A1 |
20110282378 | Murphy et al. | Nov 2011 | A1 |
20110286925 | Lerouge et al. | Nov 2011 | A1 |
20110288627 | Hartley et al. | Nov 2011 | A1 |
20110307044 | Bourang et al. | Dec 2011 | A1 |
20110307045 | Bourang et al. | Dec 2011 | A1 |
20110307046 | Bourang et al. | Dec 2011 | A1 |
20110307052 | Bourang et al. | Dec 2011 | A1 |
20110313443 | Lorenzo et al. | Dec 2011 | A1 |
20110313512 | Hartley et al. | Dec 2011 | A1 |
20110319926 | Becking et al. | Dec 2011 | A1 |
20110319928 | Griffin et al. | Dec 2011 | A1 |
20120004682 | Connor | Jan 2012 | A1 |
20120004719 | Gregorich et al. | Jan 2012 | A1 |
20120016462 | Gregorich et al. | Jan 2012 | A1 |
20120041540 | Shobayashi et al. | Feb 2012 | A1 |
20120046676 | Morsi | Feb 2012 | A1 |
20120053670 | Purdy | Mar 2012 | A1 |
20120055614 | Hancock et al. | Mar 2012 | A1 |
20120071911 | Sadasivan et al. | Mar 2012 | A1 |
20120078285 | Griffin | Mar 2012 | A1 |
20120089174 | Chen et al. | Apr 2012 | A1 |
20120116352 | Rangi | May 2012 | A1 |
20120116441 | Yamanaka et al. | May 2012 | A1 |
20120116442 | Monstadt et al. | May 2012 | A1 |
20120130479 | Chuter et al. | May 2012 | A1 |
20120143237 | Cam et al. | Jun 2012 | A1 |
20120143317 | Cam et al. | Jun 2012 | A1 |
20120165919 | Cox et al. | Jun 2012 | A1 |
20120165920 | Meyer et al. | Jun 2012 | A1 |
20120172921 | Yamanaka et al. | Jul 2012 | A1 |
20120172972 | Meyer et al. | Jul 2012 | A1 |
20120172977 | Bregulla et al. | Jul 2012 | A1 |
20120179192 | Fogarty et al. | Jul 2012 | A1 |
20120197283 | Marchand et al. | Aug 2012 | A1 |
20120209309 | Chen et al. | Aug 2012 | A1 |
20120209311 | Grandfield et al. | Aug 2012 | A1 |
20120215250 | Grandfield et al. | Aug 2012 | A1 |
20120221095 | Berez et al. | Aug 2012 | A1 |
20120238644 | Gong et al. | Sep 2012 | A1 |
20120239074 | Aboytes et al. | Sep 2012 | A1 |
20120245674 | Molaei et al. | Sep 2012 | A1 |
20120245675 | Molaei et al. | Sep 2012 | A1 |
20120253369 | Morsi | Oct 2012 | A1 |
20120253377 | Slazas et al. | Oct 2012 | A1 |
20120253448 | Hartley et al. | Oct 2012 | A1 |
20120259354 | Kellett | Oct 2012 | A1 |
20120259404 | Tieu et al. | Oct 2012 | A1 |
20120265287 | Sharma et al. | Oct 2012 | A1 |
20120271200 | Martinson et al. | Oct 2012 | A1 |
20120271399 | Perkins et al. | Oct 2012 | A1 |
20120277784 | Berez et al. | Nov 2012 | A1 |
20120283764 | Solar et al. | Nov 2012 | A1 |
20120283765 | Berez et al. | Nov 2012 | A1 |
20120283768 | Cox et al. | Nov 2012 | A1 |
20120283769 | Cruise et al. | Nov 2012 | A1 |
20120283815 | Berez et al. | Nov 2012 | A1 |
20120289995 | Constant et al. | Nov 2012 | A1 |
20120296361 | Cam et al. | Nov 2012 | A1 |
20120296362 | Cam et al. | Nov 2012 | A1 |
20120303052 | Connor | Nov 2012 | A1 |
20120303108 | Fogarty et al. | Nov 2012 | A1 |
20120303112 | Armstrong et al. | Nov 2012 | A1 |
20120310270 | Murphy et al. | Dec 2012 | A1 |
20120310271 | Kwon | Dec 2012 | A1 |
20120310611 | Sadasivan et al. | Dec 2012 | A1 |
20120316598 | Becking et al. | Dec 2012 | A1 |
20120316632 | Gao | Dec 2012 | A1 |
20120316638 | Grad et al. | Dec 2012 | A1 |
20120323268 | Martinez | Dec 2012 | A1 |
20120323309 | Cattaneo | Dec 2012 | A1 |
20120323547 | Baloch et al. | Dec 2012 | A1 |
20120330341 | Becking et al. | Dec 2012 | A1 |
20120330343 | Kim et al. | Dec 2012 | A1 |
20120330347 | Becking et al. | Dec 2012 | A1 |
20120330402 | Vad et al. | Dec 2012 | A1 |
20130012979 | Amplatz et al. | Jan 2013 | A1 |
20130018220 | Vad et al. | Jan 2013 | A1 |
20130018409 | Le et al. | Jan 2013 | A1 |
20130023903 | Roorda et al. | Jan 2013 | A1 |
20130035712 | Theobald et al. | Feb 2013 | A1 |
20130041454 | Dobson et al. | Feb 2013 | A1 |
20130045182 | Gong et al. | Feb 2013 | A1 |
20130046371 | Greenberg et al. | Feb 2013 | A1 |
20130053872 | Hansen | Feb 2013 | A1 |
20130053944 | Welch | Feb 2013 | A1 |
20130060317 | Dusbabek et al. | Mar 2013 | A1 |
20130060322 | Leynov et al. | Mar 2013 | A1 |
20130066357 | Aboytes et al. | Mar 2013 | A1 |
20130066359 | Murphy et al. | Mar 2013 | A1 |
20130066360 | Becking et al. | Mar 2013 | A1 |
20130066413 | Jin et al. | Mar 2013 | A1 |
20130066415 | Hocking | Mar 2013 | A1 |
20130072959 | Wu et al. | Mar 2013 | A1 |
20130085518 | Trommeter et al. | Apr 2013 | A1 |
20130085522 | Becking et al. | Apr 2013 | A1 |
20130089576 | Maitland et al. | Apr 2013 | A1 |
20130090682 | Bachman et al. | Apr 2013 | A1 |
20130090719 | Bales et al. | Apr 2013 | A1 |
20130090721 | Bales et al. | Apr 2013 | A1 |
20130095087 | Shalaby et al. | Apr 2013 | A1 |
20130103074 | Riina et al. | Apr 2013 | A1 |
20130103135 | Vinluan | Apr 2013 | A1 |
20130108574 | Chevalier et al. | May 2013 | A1 |
20130116659 | Porter | May 2013 | A1 |
20130116722 | Aboytes et al. | May 2013 | A1 |
20130116774 | Strauss et al. | May 2013 | A1 |
20130123830 | Becking et al. | May 2013 | A1 |
20130123899 | Leopold et al. | May 2013 | A1 |
20130123901 | Connor et al. | May 2013 | A1 |
20130131711 | Bowman | May 2013 | A1 |
20130131716 | Cruise et al. | May 2013 | A1 |
20130131780 | Armstrong et al. | May 2013 | A1 |
20130131786 | Chobotov | May 2013 | A1 |
20130146173 | Krivoruchko et al. | Jun 2013 | A1 |
20130150946 | Hartley et al. | Jun 2013 | A1 |
20130166010 | Vad | Jun 2013 | A1 |
20130166017 | Cartledge et al. | Jun 2013 | A1 |
20130172925 | Garcia et al. | Jul 2013 | A1 |
20130172975 | Berez et al. | Jul 2013 | A1 |
20130172976 | Garcia et al. | Jul 2013 | A1 |
20130190795 | Matson et al. | Jul 2013 | A1 |
20130190800 | Murphy et al. | Jul 2013 | A1 |
20130190805 | Slazas et al. | Jul 2013 | A1 |
20130197547 | Fukuoka et al. | Aug 2013 | A1 |
20130197570 | Ebata et al. | Aug 2013 | A1 |
20130197617 | Armstrong et al. | Aug 2013 | A1 |
20130197624 | Armstrong et al. | Aug 2013 | A1 |
20130204288 | Johnson et al. | Aug 2013 | A1 |
20130204289 | Dasnurkar et al. | Aug 2013 | A1 |
20130204290 | Clarke et al. | Aug 2013 | A1 |
20130204347 | Armstrong et al. | Aug 2013 | A1 |
20130204351 | Cox et al. | Aug 2013 | A1 |
20130204354 | Adams | Aug 2013 | A1 |
20130211443 | Cragg et al. | Aug 2013 | A1 |
20130211492 | Schneider et al. | Aug 2013 | A1 |
20130211497 | Charlebois et al. | Aug 2013 | A1 |
20130211498 | Buckley et al. | Aug 2013 | A1 |
20130211505 | Robison | Aug 2013 | A1 |
20130211507 | LaDuca et al. | Aug 2013 | A1 |
20130218191 | Heltai | Aug 2013 | A1 |
20130226276 | Newell et al. | Aug 2013 | A1 |
20130226278 | Newell et al. | Aug 2013 | A1 |
20130231695 | Malek | Sep 2013 | A1 |
20130231732 | Vonderwalde et al. | Sep 2013 | A1 |
20130238083 | Duggal et al. | Sep 2013 | A1 |
20130245606 | Stam et al. | Sep 2013 | A1 |
20130245667 | Marchand et al. | Sep 2013 | A1 |
20130245745 | Vong et al. | Sep 2013 | A1 |
20130252900 | Reb et al. | Sep 2013 | A1 |
20130253086 | Wilson et al. | Sep 2013 | A1 |
20130253572 | Molaei et al. | Sep 2013 | A1 |
20130253631 | Schmid et al. | Sep 2013 | A1 |
20130253634 | Wilson et al. | Sep 2013 | A1 |
20130261728 | Perkins et al. | Oct 2013 | A1 |
20130261730 | Bose et al. | Oct 2013 | A1 |
20130261732 | Perkins et al. | Oct 2013 | A1 |
20130267986 | Hines | Oct 2013 | A1 |
20130268046 | Gerberding et al. | Oct 2013 | A1 |
20130268053 | Molaei et al. | Oct 2013 | A1 |
20130274862 | Cox et al. | Oct 2013 | A1 |
20130274863 | Cox et al. | Oct 2013 | A1 |
20130274866 | Cox et al. | Oct 2013 | A1 |
20130274868 | Cox et al. | Oct 2013 | A1 |
20130282096 | Berez et al. | Oct 2013 | A1 |
20130289690 | Thapliyal | Oct 2013 | A1 |
20130289713 | Pearson et al. | Oct 2013 | A1 |
20130289714 | Strauss et al. | Oct 2013 | A1 |
20130302251 | Constant et al. | Nov 2013 | A1 |
20130304109 | Abrams et al. | Nov 2013 | A1 |
20130310687 | Takizawa et al. | Nov 2013 | A1 |
20130325053 | Porter et al. | Dec 2013 | A1 |
20130331883 | Strauss et al. | Dec 2013 | A1 |
20130338688 | Rehman et al. | Dec 2013 | A1 |
20130344159 | Moine et al. | Dec 2013 | A1 |
20130345738 | Eskridge | Dec 2013 | A1 |
20130345785 | Hartley et al. | Dec 2013 | A1 |
20140005698 | Eskridge | Jan 2014 | A1 |
20140012303 | Heipl | Jan 2014 | A1 |
20140012307 | Franano et al. | Jan 2014 | A1 |
20140012363 | Franano et al. | Jan 2014 | A1 |
20140018843 | Berez et al. | Jan 2014 | A1 |
20140018902 | Myr | Jan 2014 | A1 |
20140025151 | Gao | Jan 2014 | A1 |
20140025154 | Liang et al. | Jan 2014 | A1 |
20140031858 | Bhagchandani et al. | Jan 2014 | A1 |
20140031918 | Newell et al. | Jan 2014 | A1 |
20140031920 | Malek | Jan 2014 | A1 |
20140039536 | Cully et al. | Feb 2014 | A1 |
20140039606 | Rudakov et al. | Feb 2014 | A1 |
20140046338 | Grandfield et al. | Feb 2014 | A1 |
20140047694 | Monstadt et al. | Feb 2014 | A1 |
20140052168 | Sawhney | Feb 2014 | A1 |
20140052233 | Cox et al. | Feb 2014 | A1 |
20140058420 | Hannes et al. | Feb 2014 | A1 |
20140058436 | Rosenbluth et al. | Feb 2014 | A1 |
20140058498 | Hannes et al. | Feb 2014 | A1 |
20140058500 | Lundkvist et al. | Feb 2014 | A1 |
20140074149 | Garcia et al. | Mar 2014 | A1 |
20140081313 | Elliott | Mar 2014 | A1 |
20140081374 | Kim et al. | Mar 2014 | A1 |
20140082924 | Lundkvist et al. | Mar 2014 | A1 |
20140083969 | Porter | Mar 2014 | A1 |
20140088690 | Fogarty et al. | Mar 2014 | A1 |
20140094896 | Berez et al. | Apr 2014 | A1 |
20140099374 | Golzarian et al. | Apr 2014 | A1 |
20140100647 | Bourang | Apr 2014 | A1 |
20140114342 | Berez et al. | Apr 2014 | A1 |
20140114343 | Lee et al. | Apr 2014 | A1 |
20140121744 | Kusleika | May 2014 | A1 |
20140121745 | Kusleika et al. | May 2014 | A1 |
20140121746 | Kusleika et al. | May 2014 | A1 |
20140121752 | Losordo et al. | May 2014 | A1 |
20140128901 | Kang et al. | May 2014 | A1 |
20140128907 | Hui et al. | May 2014 | A1 |
20140128957 | Losordo et al. | May 2014 | A1 |
20140130965 | Banks et al. | May 2014 | A1 |
20140135810 | Divino et al. | May 2014 | A1 |
20140135811 | Divino et al. | May 2014 | A1 |
20140135812 | Divino et al. | May 2014 | A1 |
20140142611 | Plaza et al. | May 2014 | A1 |
20140163604 | Monstadt | Jun 2014 | A1 |
20140172001 | Becking et al. | Jun 2014 | A1 |
20140172067 | Brown et al. | Jun 2014 | A1 |
20140172071 | Berez et al. | Jun 2014 | A1 |
20140180377 | Bose et al. | Jun 2014 | A1 |
20140180387 | Khenansho et al. | Jun 2014 | A1 |
20140180397 | Gerberding et al. | Jun 2014 | A1 |
20140188208 | Hancock et al. | Jul 2014 | A1 |
20140194973 | Chobotov | Jul 2014 | A1 |
20140200607 | Sepetka et al. | Jul 2014 | A1 |
20140200648 | Newell et al. | Jul 2014 | A1 |
20140207162 | Tran et al. | Jul 2014 | A1 |
20140207180 | Ferrera | Jul 2014 | A1 |
20140214071 | Thomas | Jul 2014 | A1 |
20140222128 | Dusbabek et al. | Aug 2014 | A1 |
20140222130 | Kusleika | Aug 2014 | A1 |
20140236216 | Gerberding | Aug 2014 | A1 |
20140243951 | Orr | Aug 2014 | A1 |
20140249614 | Levi et al. | Sep 2014 | A1 |
20140249616 | Strauss et al. | Sep 2014 | A1 |
20140249620 | Carman et al. | Sep 2014 | A1 |
20140260928 | Janardhan et al. | Sep 2014 | A1 |
20140265096 | Janardhan et al. | Sep 2014 | A1 |
20140277100 | Kang | Sep 2014 | A1 |
20140277361 | Farhat et al. | Sep 2014 | A1 |
20140277370 | Brocker et al. | Sep 2014 | A1 |
20140277391 | Layman et al. | Sep 2014 | A1 |
20140288633 | Burke et al. | Sep 2014 | A1 |
20140296358 | Maitland et al. | Oct 2014 | A1 |
Number | Date | Country |
---|---|---|
PCTUS2009002537 | Apr 2009 | WO |
Entry |
---|
U.S. Appl. No. 12/387,637, filed 2009, Connor et al. |
U.S. Appl. No. 13/889,451, filed 2013, Connor et al. |
Number | Date | Country | |
---|---|---|---|
Parent | 12592116 | Nov 2009 | US |
Child | 14562725 | US |